Targeting c-Kit mutations: basic science to novel therapies
- 31 May 2004
- journal article
- review article
- Published by Elsevier BV in Leukemia Research
- Vol. 28, 11-20
- https://doi.org/10.1016/j.leukres.2003.10.004
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Pharmacology of imatinib (STI571)European Journal of Cancer, 2002
- Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal TumorsNew England Journal of Medicine, 2002
- Chromosomal aberrations in malignant gastrointestinal stromal tumors: correlation with c-KIT gene mutationCancer Genetics and Cytogenetics, 2001
- Effect of the Tyrosine Kinase Inhibitor STI571 in a Patient with a Metastatic Gastrointestinal Stromal TumorNew England Journal of Medicine, 2001
- KIT Extracellular and Kinase Domain Mutations in Gastrointestinal Stromal TumorsThe American Journal of Pathology, 2000
- Isoforms of c-KIT differ in activation of signalling pathways and transformation of NIH3T3 fibroblastsOncogene, 1999
- Gain-of-Function Mutations of c- kit in Human Gastrointestinal Stromal TumorsScience, 1998
- Direct Association of Csk Homologous Kinase (CHK) with the Diphosphorylated Site Tyr568/570 of the Activated c-KIT in MegakaryocytesPublished by Elsevier BV ,1997
- Expression of stem-cell factor and its receptor c-kit protein in normal testicular tissue and malignant germ-cell tumoursZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.JCI Insight, 1993